Menu

    COVID-19 testing: rapid antigen tests and testing strategies - Highlights from the report of the European Commission - RIDACOM Webinar - 24 November 2020

    24.11.2020

    Dear Partners and Friends,

    On 19.10.2020 A summary report of the European Health Commission's COVID-19 meeting, which brought together participants from more than 30 countries and organizations, was published.

    The main topic discussed at this meeting is the introduction of rapid antigen tests in the diagnosis of SARS-CoV-2.

    Based on the details provided on the types of rapid antigen tests being used or considered, countries focus so far on five tests:

    • SD Biosensor/ROCHE
    • Abbott
    • ArcDia
    • Coris Bioconcept
    • Quidel


    The most considered options are:

    • SD Biosensor / ROCHE - used or considered by 9 countries
    • Abbott - used or considered by 7 countries


    The majority of countries (13/15) were in favour of a common EU approach to the use of rapid antigen tests.

    In response to that recommendations on the use of rapid antigen tests for the diagnosis of SARS-CoV-2 infection were published on November 18, 2020 by the European commission.

    We invite you to join our webinar on 24.11.2020, 2:00 PM, where detailed information will be provided.


    ???? 14:00 PM 24.11.2020г
    ???? Virtual room: https://zoom.us/j/5300796125…
    ???? ID of the meeting: 530 079 6125
    ???? Password: 2020


    References:

    https://ec.europa.eu/health/sites/health/files/preparedness_response/docs/ev_20201019_sr_en.pdf

    https://www.medrxiv.org/content/10.1101/2020.10.13.20211524v2.full-text#disqus_thread